US 2016/0243030 A1Published application

Aqueous Ophthalmic Composition

AssigneeRohto Pharmaceutical Co., Ltd.

InventorsRyo Komurasaki, Yoko Mizutare, Atsuko Nakata

Life of this patent

Estimating the term…

Abstract

The present invention relates to an aqueous ophthalmic composition comprising (A) polyoxyethylene castor oil, (B) polyethylene glycol monostearate, and (C) at least one member selected from the group consisting of sesame oil, castor oil, vitamin A, and chlorobutanol.

Claims12

Dependent claims

1-7. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 15/147,415Filed 5 May 2016
Priority: JP P2012-2658414 Dec 2012
Published: 25 Aug 2016
Term ends: Not estimatedThe source records don’t support an estimate.

Classification13 codes

A61K 47/44
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents…: oils,…
A01N 25/22
Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by…
A01N 37/36
Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to…:…
A61K 9/0048
Galenical forms characterised by the site of application: eye, e.g. artificial tears

Family

Application14/384,810Continuation · filed 12 Sep 2014
Application15/147,415Continuation
US 2015/0018416 A1Published application
US 9,427,473 B2Related patent
US 2016/0243030 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results